Preventing Pressure Injury
kfedyszyn@hmpg…
Fri, 10/24/2025 – 12:09
A Primer on Pressure Injury Etiology

Pressure injuries present a significant clinical challenge with substantial morbidity, mortality, and economic burden. The etiology of these wounds is complex and multifactorial, involving an interplay of intrinsic and extrinsic factors that lead to tissue damage. Understanding these foundational elements is crucial for effective prevention and treatment.
Select CountryAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo – BrazzavilleCongo – KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkeyTurkmenistanTurks & Caicos IslandsTuvaluU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands
Select ProfessionAdministratorBilling/Coding SpecialistCase ManagerCEO/CFO/CIO/CNO/COOClinical CoordinatorCompliance CoordinatorConsultantDermatologistDietitianDirector of NursingDirector of Risk ManagementGeriatricianGPO Contract ManagerHospice DirectorMaterials ManagementMedical DirectorNurse – LPNNurse – RNNurse – Wound CareNurse PractitionerNurse SpecialistNurse SupervisorOccupational TherapistOtherPharmacistPhysical TherapistPhysicianPhysician AssistantPodiatristPresident/VPProfessorProgram DirectorPurchasing DirectorQuality AssuranceRisk ManagementSurgeon – BurnSurgeon – GeneralSurgeon – Plastic & ReconstructiveSurgeon – VascularWound Care Coordinator
Select Work SettingAcute CareAssisted LivingBurn CenterGeneral PracticeGovernment AgencyHome HealthHospiceHospital – Independent/Community Hospital SystemHospital – VAHyperbaric CenterIndustryInfection Control/PreventionInternal Medicine PracticeLong-Term CareLong-Term/Acute Care (LTAC)MilitaryOtherOutpatient ClinicPharmacyPhysical TherapyPrivate Practice/Office-basedResearchSpecialized/Rehab CenterUniversity/SchoolWound Care Center/Clinic
By submitting your information through this form, you confirm that you agree to WoundSource’s Privacy Policy, as well as sharing your information with any partners for marketing purposes. You can opt out at any time.
Demystifying Pressure Injury Staging
This webinar will help guide practitioners towards more accurate pressure injury staging, using clinical examples to inspire the discussion. The faculty will emphasize how accurate staging can inform risk assessment and prevention efforts, along with treatment choices. Particular areas of complexity will be discussed, such as clearly defining “unstageable” pressure injuries and other clinical conundrums.
Dot Weir, RN, CWON, CWS

Assessing Patients for Pressure Injury Risk
November 3, 2025
Transcript
Hi, my name is Cathy Milne, and I am the editor of WoundSource as well as the co-chair for WoundCon. I am so glad to have you with me today.
So, we are talking about pressure injury risk assessment tools. So, it’s very, very interesting when you start looking at the literature. So, I think the first question I get is that there are several risk tools out there. There’s the Braden scale, the Norton scale, the Waterlow scale, in fact there’s over 40 scales out there in the literature. And so the question is, that I always get, is how effective are these tools? Well, it really depends.
So, one of the things that we have to think about is what is there, there are no requirements that we use a certain scale in our risk assessment. What we need to do, because a risk assessment tool is a planning tool. It is not an intervention. It helps guide you into where you need to individualize the patient’s care. So, if you start looking at the more common scales out there, and that would be the Braden, the Norton, the Waterlow, then you have to look at the literature, and it’s out there. It’s not even—AI can tell you about how sensitive and specific these tools are, but that varies by setting. And so you might have a tool that works better in critical care than it does in home health. And clearly, the pediatric patient population has their own scales because they’re different kind of species, right? They’re smaller, their skin may be, if they’re neonates, they’re not well developed. So, you have to think, where am I going to use this scale? And what is the specificity and accuracy of these tools?
Now, that being said, I do want to say one thing. There are some limitations you need to know of. The Braden is no longer free by getting on the Braden website. That has now been sold to a group of people who have now taken this scale, and they offer other materials along with the use of the scale. So, if you haven’t gotten permission from them, you really should start talking with your legal department and with these people who now own the copyright to the scale. And then you can work it out from there, but please be mindful that this is no longer Barbara Braden’s property. Poor Barbara Braden, you know, passe a few years ago. And her only requirement is that you register with her site. This is now changed. So please, please, please look at bradenscale.com and follow the lead there.
So, now you have a scale number. So, let’s take the Braden Scale or the Norton scale or the Waterlow scale. So, it comes up with a number, and then you are to use it. But most the common thing that I see is that people use that total number instead of looking at the subset scores. So, you might still be greater than, let’s say for the Brayden scale or the Norton scale, you are no longer at risk, you’re not deemed at risk. But if you look at the subscale, so let’s say you walk well, you can transfer well, you eat well, but you are incontinent all the time. Now your moisture scale will be very, very low or very, very high, depending on which scale you’re looking at. But anyway, everything else is normal except for this one subset. So, that’s what puts you at risk. So, you should be planning your interventions on the subscales, not the total altogether. You may have a score that shows you’re at high risk for breakdown, but you still have to look at that they’re still at high risk, but focus on those subscores, because that’s where targeted interventions will make a huge difference.
Now, one of the things that we should be thinking about is it’s really not the scale that you’re using, it is what you do with the scale. So, it’s all about the intervention. So, when you look at the Cochrane review and other meta-analysis, it’s not the individual scale applied. It’s part of the bundle of interventions. The interventions for pressure injury prevention are risk assessment, a physical exam of the patient, targeted interventions that are focused on friction reduction, shear reduction, moisture reduction, nutritional interventions to improve the patient’s overall health. So, those are the basics, but we also have to think about the things that are not covered in the majority of these scales. And that is the comorbidities.
There’s one out in England that they’re using, I think it’s called the Cubbin/Jackson pressure injury risk assessment. It’s very, it’s wonderful. However, it’s very long. We in the US probably don’t have time to implement it. And we also would have problems with integrating it into our EMR because of the algorithmic ability of this scale. However, so it’s once you come up with that assessment. So, again, risk assessment, physical exam, interventions targeted at specific areas where you have identified at risk, including diabetes, age—if you’re over 65, you are at risk—a low hemoglobin. There are over 100 risk factors out there that will make you more prone to a pressure injury. For critical care, we know it’s respiratory failure and the use of vasopressors. So, you have to tailor those additional factors of the patient to the clinical setting.
Now, we have to start thinking about emerging tools and technologies; it’s out there, and they’re wonderful. So, when we start to look at who has developed a pressure injury, we only wait until our eyes show us something, right? What we should be thinking about, and if our institution can support us, we should be looking at technologies. There’s infrared technology, there’s ultrasound technology. And there are other things probably in the works right now that may help us predict pressure injury or actually discover pressure injury before our eyes see it. And that’s good for us in terms of a regulatory aspect, but these technologies don’t help us prevent. They help us see things that have already occurred before we see them.
Now, will AI come up with something in the near future or even the distant future? There’s probably a really good indication out there that you might be able to predict algorithmically and there’s a great intro article literature that was written by Dr. William Padula that talks about this. So, I think the future for prevention and early intervention is going to be wide open for us. And I’m looking forward to the future.
The views and opinions expressed in this content are solely those of the contributor, and do not represent the views of WoundSource, HMP Global, its affiliates, or subsidiary companies.
Medical Device–Related Pressure Injury: What Wound Care Teams Need to Know
November 3, 2025
Medical device-related pressure injury (MDRPI) is a distinct subset of pressure injury that occurs when a diagnostic or therapeutic device exerts sustained pressure or shear at the skin-device interface, often over bony prominences or along lines, tubing, masks, and collars. The result can be tissue ischemia, inflammation, and ulceration that mirrors the device’s shape and contact points.1,2 MDRPI is frequently underrecognized because devices are essential to care and because skin under or adjacent to the device is not always inspected as reliably as conventional risk areas. As device use expands across acute and post‑acute settings, from noninvasive ventilation to monitoring leads, awareness and prevention are now core competencies for wound care teams across the continuum. Foundational overviews and meta‑analyses emphasize both the clinical significance and the need for standardized prevention approaches.1,2
Incidence estimates vary widely by device type, population, and care environment, reflecting discrepancy in definitions, surveillance, and risk profiles. Meta‑analytic work underscores the idea that MDRPI is common, particularly in critical care settings and among patients requiring respiratory support or hemodynamic monitoring, but rates differ substantially across studies and settings.1,3 Regardless of the precise rate in a given unit, the clinical and operational consequences, including pain, infection risk, treatment delays, extended length of stay, and additional costs, are relatively consistent. A shared challenge is that device necessity competes with offloading opportunities, and the tight tolerances needed for device performance (eg, mask seal, cervical immobilization) can amplify pressure and shear.2
MDRPI risk is multifactorial and includes patient, device, and care‑process contributors. Patient‑level factors associated with MDRPI include immobility, altered perfusion or hemodynamics, edema, compromised sensation or consciousness, fever, moisture, and poor nutritional status; lower skin tolerance from age‑related changes or comorbidities can also magnify these risks.2,4 Device‑level risks include rigid materials, rough or narrow edges, inadequate padding, incorrect sizing, high strap or securement tension, and prolonged uninterrupted wear time.4 Care‑process risks span inconsistent skin inspection, lack of device‑specific risk screening, poorly timed repositioning relative to device checks, and delayed escalation when early skin changes are noted.2,4,5 In the ICU, the combination of vasopressors, sedation, respiratory devices, and limited repositioning time windows can compound vulnerability.4
Because MDRPI arises at predictable device-skin interfaces, prevention hinges on structured care protocols that integrates device fit, microclimate management, and timely offloading into routine workflows. Systematic reviews of interventional strategies describe bundles that pair device‑specific risk assessment with frequent targeted skin checks, use of prophylactic dressings at high‑risk contact points, strap or fixation retensioning, scheduled device repositioning or offloading, moisture and heat control, and early device removal when no longer clinically necessary.6,7 Protocols also embed interprofessional roles (eg, respiratory therapy adjusting mask fit, nursing monitoring skin and microclimate, physical therapy supporting positioning, physicians reevaluating device indications) to ensure that prevention does not depend on a single discipline.6,5
Skin inspection must literally reach under and around devices. When visualization is limited, as in the case of immobilization devices, documented checks of adjacent areas and consideration of temporary “device holidays” guided by the care team can still reduce cumulative load.2,5 In addition, fit testing should not be considered a one‑time event: changes in edema, weight, or sedation can convert a previously safe interface into a hazardous one. Securement should minimize shear and “tourniquet effect,” using anchoring points that distribute load more broadly; switching to softer, wider ties or fixation, and avoiding excessive strap tension when a good seal is already achieved, are practical adjustments.2,5
Prophylactic dressings are frequently included in strategic bundles. Reviews note that silicone‑bordered foam and similar low‑friction, low‑shear dressings can reduce contact stress at masks, tubing, and collar edges, especially when combined with fit optimization and moisture control.6,7 Dressings are not substitutes for offloading, however, and must be applied in ways that do not impede device function. Microclimate also matters; trapped heat and humidity under devices degrade skin tolerance, and strategies such as moisture‑wicking interfaces, periodic drying, and timely replacement of damp materials can help address these issues to mitigate addition MDRPI risk.2,5,7
Education, audit, and feedback sustain prevention efforts over time. MDRPI‑specific training, including using device photos, pressure maps, and case reviews, builds shared mental models so that early detection can trigger action rather than watchful waiting. Evidence from protocol implementation studies suggests that standardized bundles are associated with reductions in MDRPI, though heterogeneity in study design and outcome definitions warrants cautious interpretation and ongoing quality improvement.6,7
Across the continuum, the same principles apply: in the emergency department, prevent damage during the high‑throughput, high‑device‑intensity window; in the ICU, pair device checks with sedation or ventilator bundles; on wards and in long‑term or home settings, protect skin from oxygen cannulae, feeding tubes, catheters, and compression interfaces that may persist for weeks. Documentation should identify the device, location, earliest observed changes, and actions taken; consistent nomenclature improves surveillance and handoffs.2,5 Ultimately, MDRPI prevention is the sum of small, reliable practices—seeing under devices, fitting them thoughtfully, protecting microclimate, and offloading whenever safely possible—delivered by teams working from shared protocols and data.2,5-7
References
1. Jackson D, Sarki AM, Betteridge R, Brooke J. Medical device-related pressure ulcers: A systematic review and meta-analysis. Int J Nurs Stud. 2019;92:109-120. doi:10.1016/j.ijnurstu.2019.02.006
2. Pittman J, Gillespie C. Medical Device-Related Pressure Injuries. Crit Care Nurs Clin North Am. 2020;32(4):533-542. doi:10.1016/j.cnc.2020.08.004
3. Zhang N, Li Y, Li X, et al. Incidence of medical device-related pressure injuries: a meta-analysis. Eur J Med Res. 2024;29(1):425. doi:10.1186/s40001-024-01986-2
4. Gou L, Zhang Z, A Y. Risk factors for medical device-related pressure injury in ICU patients: A systematic review and meta-analysis. PLoS One. 2023;18(6):e0287326. doi:10.1371/journal.pone.0287326
5. Çakar V, Karadağ A. Best Practices in Medical Device‑Related Pressure Injuries. J Educ Res Nurs. 2024;21(4):350‑356.
6. Lee H, Choi S. Protocols and their effects for medical device-related pressure injury prevention among critically ill patients: a systematic review. BMC Nurs. 2024;23(1):403. doi:10.1186/s12912-024-02080-y
7. Lyu Y, Huang YL, Li ZY, Lin F. Interventions and strategies to prevent medical device-related pressure injury in adult patients: A systematic review. J Clin Nurs. 2023;32(19-20):6863-6878. doi:10.1111/jocn.16790
The views and opinions expressed in this content are solely those of the contributor, and do not represent the views of WoundSource, HMP Global, its affiliates, or subsidiary companies.
What’s New (and What’s Next) in the 2025 International Pressure Injury Guideline
November 3, 2025
As pressure injury prevention and treatment continue to span acute, post-acute, and home settings, the International Guideline remains the field’s north star. In 2025, partner organizations National Pressure Injury Advisory Panel (NPIAP), European Pressure Ulcer Advisory Panel (EPUAP), and Pan Pacific Pressure Injury Alliance (PPPIA) are rolling out the fourth edition of this guideline with an expanded online format and staged release of chapters, plus refreshed quick-reference materials for busy clinicians.1
Governance is provided by the Guideline Governance Group (GGG), established jointly by NPIAP/EPUAP/PPPIA and led by Professor Janet Cuddigan, PhD, RN, FAAN. The 2025 development team includes more than 240 clinical experts and consumer representatives across panel groups who shape evidence-to-decision (EtD) frameworks, review recommendations, and advise on implementation and consumer materials.1
Methodologically, the 2025 edition follows GRADE, a widely regarded gold standard, using prespecified clinical questions (PICOT), comprehensive literature searches, standardized risk-of-bias tools (eg, RoB 2, ROBINS-I), meta-analysis where appropriate, and transparent EtD frameworks to determine both the certainty of evidence and strength of recommendations.2
Two resources from the prior edition, published in 2019, remain freely available and highly useful for day-to-day practice. The full 2019 Clinical Practice Guideline (CPG) is a deep dive into evidence summaries, implementation considerations, and discussion.3 Meanwhile, the 2019 Quick Reference Guide (QRG) is explicitly designed for busy health professionals as a concise summary of evidence-based recommendations and good-practice statements, though it should not be used in isolation from the full CPG.4
For 2025, the guideline team is publishing topic-based chapters online as they’re finalized. Chapters live as of November 1, 2025, include Definition & Etiology, Preventive Skin Care, Nutrition, Repositioning, Support Surfaces, Seating, Heel Pressure Injuries, and Device-Related Pressure Injuries, with additional sections coming soon to include Pressure Injury Risk and Skin and Tissue Assessment.1
There is also an abridged 2025 Quick Reference Guide, which features “recommendations and good practice statements are extracted from the full Clinical Practice Guideline (CPG) for convenience of use in clinical practice.”5 This document is expected to be updated as further sections of the full CPG are made available.
The online guideline hub is live in beta (desktop-optimized), and consolidates chapters, methods, and navigation in one place. A mobile version is also planned.1
How Clinicians Can Use These Now
- At the bedside and in huddles: Reach first for the QRG to check “what to do,” then open the corresponding online 2025 chapter (or the 2019 CPG for topics where 2025 content isn’t yet posted) for “how and why,” including implementation considerations and the graded certainty/strength for each recommendation.3-5
- For protocols and education: Align local policies with the newest posted prevention chapters.1
- For quality projects: Use the methods pages and linked EtD frameworks to justify priority interventions and to educate teams on how certainty of evidence informs the strength of recommendations, which may be useful when negotiating equipment budgets, staffing for repositioning, or nutrition support pathways.2
Looking Ahead
Several sections, including Pressure Injury Risk, Skin & Tissue Assessment, and the Glossary, are flagged on the site as “content coming soon.”1 Meanwhile, the methods team notes that PICOT searches will be published as they are conducted, so additional content and updates will appear iteratively on the site.2 A mobile version of the online guideline is also planned.1
While more guideline information continues to emerge, clinicians may consider using the 2019 CPG/QRG together with the published 2025 chapters to refresh their practices over the coming months. Interested parties may choose to bookmark the beta online guideline hub, and check back regularly as remaining chapters and tools go live.
References
- NPIAP/EPUAP/PPPIA. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. 2025. Accessed October 2025. Available at: https://internationalguideline.com/the-international-guideline
- NPIAP/EPUAP/PPPIA. Prevention and Treatment of Pressure Ulcers/Injuries: Methodology Protocol for the Clinical Practice Guideline (fourth edition). 2023. Accessed October 2025. Available at: https://static1.squarespace.com/static/6479484083027f25a6246fcb/t/679fe…
- NPIAP/EPUAP/PPPIA. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. The International Guide 2019. Emily Haesler, Ed. Accessed October 2025. Available at: https://static1.squarespace.com/static/6479484083027f25a6246fcb/t/6553d…
- NPIAP/EPUAP/PPPIA. Prevention and Treatment of Pressure Ulcers/Injuries: Quick Reference Guide 2019. Emily Haesler, Ed. Accessed October 2025. Available at: https://static1.squarespace.com/static/6479484083027f25a6246fcb/t/647dc…
- NPIAP/EPUAP/PPPIA. Prevention and Treatment of Pressure Ulcers/Injuries: Quick Reference Guide. The International Guideline: Fourth Edition. Emily Haesler, Ed. 2025. Accessed October 2025. Available at: https://static1.squarespace.com/static/6479484083027f25a6246fcb/t/67bd4…
The views and opinions expressed in this content are solely those of the contributor, and do not represent the views of WoundSource, HMP Global, its affiliates, or subsidiary companies.






